Error: Could not add to watchlist. X

Medivir AB

+ Watchlist
MVIRB:SS
Stockholm
74.75
SEK
1.25
1.64%
As of 06:30:14 ET on 09/01/2015.
Open
75.75
Day Range
74.75 - 75.75
Volume
29,529
Previous Close
76.00
52Wk Range
69.00 - 131.13
1 Yr Return
-37.06%
Open
75.75
Day Range
74.75 - 75.75
Volume
29,529
Previous Close
76.00
52Wk Range
69.00 - 131.13
1 Yr Return
-37.06%
YTD Return
-18.48%
Current P/E Ratio (TTM)
3.79
Earnings per Share (SEK) (TTM)
20.05
Market Cap (b SEK)
2.049
Shares Outstanding (m)
26.360
Price/Sales (TTM)
1.64
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Medivir AB is a medical research company. The Company develops new drugs and pharmaceutical compounds based on proteases and polymerases as target enzymes. Medivir focuses on infectious and immunological diseases including projects against HIV, jaundice, shingles, multiple sclerosis, and rheumatoid arthritis. The Company is located in Huddinge, Sweden and Cambridge, United Kingdom.
ADDRESS
Lunastigen 7
Huddinge, 141 44
Sweden
PHONE
46-8-546-831-00
  • Niklas Prager
    President/CEO
  • Ola Burmark
    CFO
  • Christine Lind
    Exec VP:Strategic Business Dev
  • Richard Bethell
    Exec VP:Discovery Research
  • Henrik Krook
    Exec VP:Commercial
Show More